Go back to all articles
ENA panel (screening)
An extractable nuclear antigen (ENA) panel detects the presence of one or more autoantibodies in the blood that react with proteins in the cell nucleus. These proteins are known as “extractable” because they can be removed from cell nuclei using saline. Autoantibodies are produced when a person’s immune system mistakenly targets and attacks the body’s own tissues. This attack can cause inflammation, tissue damage, and other signs and symptoms that are associated with an autoimmune disorder. Certain autoimmune disorders are characteristically associated with the presence of one or more anti-ENA antibodies. This association can be used to help diagnose an autoimmune disorder and to distinguish between disorders.
Sample:
Blood (serum)
Reference:
Negative
Frequency:
Twice a week
This article could be of your interest
News
01/04/24
Tackling the Rising Demand for Diagnostic Testing
Planned efforts by stakeholders in the healthcare industry may resolve the challenges in diagnostic testing
READ MORE
News
01/04/24
Global Sustainability Survey Reports Progress Toward Greener Labs
Laboratories seek to actively participate and accelerate sustainability efforts
READ MORE
News
13/03/24
Why do we have World Diabetes Awareness Day?
Diabetes is an illness that is purely determined by the laboratory, because the diagnosis of diabetes is 100% dependent on the lab’s test result.
READ MORE